Synergy CHC Corp. reported GAAP earnings per share of -$0.23 and revenue of $5.49 million [1] for the quarter ended March 31, 2026.
The results indicate a downturn in profitability for the NASDAQ-listed company, which failed to meet analyst expectations for the period.
Financial data released earlier this month shows the company's current performance is a reversal from previous years. In the first quarter of 2025, the company reported a GAAP EPS of 0.10 [1]. This shift from a profit to a loss highlights the volatility facing the firm's operations.
Market analysts had anticipated a more positive outcome for the company. The Zacks Consensus EPS estimate for the first quarter of 2026 was 0.03 [1], a figure the company missed by a wide margin.
The company's reported revenue of $5.49 million [1] was also a point of scrutiny. While some reports rounded this figure to $5.5 million [2], the detailed financial filings confirm the specific total. This revenue figure reflects the company's total intake for the three months ending in March.
Synergy CHC Corp. is headquartered in the U.S. and serves as a publicly traded entity on the NASDAQ exchange. The company released these figures to provide transparency to investors and the broader market regarding its financial health and operational trajectory.
Because the company missed both its own prior-year benchmarks and the consensus estimates from analysts, the stock's performance may face pressure as investors reevaluate the company's growth prospects.
“Synergy CHC Corp. reported GAAP earnings per share of -$0.23”
The transition from a positive EPS of 0.10 in 2025 to a loss of 0.23 in 2026 suggests a deterioration in operational efficiency or an increase in costs that the company's current revenue cannot cover. Missing the Zacks consensus estimate further indicates that the company is underperforming relative to market expectations, which typically leads to increased investor scrutiny and potential stock price volatility.
